// App-Quantinova.ai

: Early Use of Antibiotics and Unfavorable Results after Allogeneic Hematopoietic Stem Cell Transplantation, a Competing Risk Analysis in a Cohort of 274 Patients

Researchers

Presenter

  • Pamela Velásquez-Salazar

Principal Investigators

  • Amado J Karduss

  • Gilma N Hernandez

  • Angelica Cardona

  • Hector Ivan Garcia

Medical Centers

  • University of Antioquia-Clinical Epidemiology Academic Group-GRAEPIC, Medellin, Colombia

  • University of Antioquia, Medellin, Colombia

  • Research Unit, IDC Cancer Research Group, Auna Ideas Foundation, Medellin, Colombia

  • Bone Marrow Transplantation Program, Cancer Institute Las Americas AUNA, Medellin, Colombia

Locations

  • Colombia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Graft-versus-host disease

  • Acute Leukemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • vancomycin capsule

  • Meropenem

  • Cefepime

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved